SQIDF News Alert Sqi Diagnostics Inc (SQIDF) 0.3850 02/15/2015
Post# of 64074
Posted On: 02/15/2015 3:01:30 PM
Sqi Diagnostics Inc (SQIDF) 0.3850 $SQIDF
SQI Diagnostics Completes Tranche of Debenture Financing
CNW Group - Fri Jan 30, 2:01PM CST
SQI Diagnostics Inc. ("SQI" or the "Company"
(TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it has closed the first tranche of its previously announced non-brokered private placement (the "Offering" of secured debentures for gross proceeds of $1.95 million.
SQD.VN: 0.560 (-0.010)
SQI Diagnostics Announces Debt Financing of up to $4 Million
CNW Group - Wed Jan 21, 3:53PM CST
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES.
SQD.VN: 0.560 (-0.010)
SQI Diagnostics Reports Fourth Quarter and Fiscal 2014 Results
CNW Group - Wed Dec 17, 3:05PM CST
Solid Customer Growth Positions for Revenue Velocity in 2015
SQD.VN: 0.560 (-0.010)
SQI Diagnostics Wins Additional Business from UK-based Customer
PR Newswire - Mon Dec 15, 9:32AM CST
Technology Transfer Agreement Signals Revenue Growth Opportunities
SQD.VN: 0.560 (-0.010)
SQI Diagnostics to Announce Fourth Quarter and Fiscal 2014 Results
PR Newswire - Wed Dec 10, 4:00PM CST
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company" (TSX-V: SQD; OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it plans to release its financial and operational results for the fourth quarter and fiscal year ended September 30, 2014, after market close on Wednesday, December 17, 2014.
SQD.VN: 0.560 (-0.010)
S&P Capital IQ Initiates Coverage on SQI Diagnostics Inc. in S&P Capital IQ Factual Stock Reports
PR Newswire - Tue Dec 09, 5:10PM CST
S&P Capital IQ (MHFI) announced today that it has commenced Factual Stock Report coverage on SQI Diagnostics Inc.
MHFI: 102.19 (unch), SQD.VN: 0.560 (-0.010)
SQI DIAGNOSTICS Advances Commercial Opportunity with Leading Global Pharmaceutical Customer
PR Newswire - Mon Nov 24, 7:00AM CST
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company" (TSX-V: SQD) (OTCQX: SQIDF) today announced that it has expanded its existing commercial relationship with one of the world's largest pharmaceutical companies. This final step in commercializing the Company's Ig_plex™ platform could lead to significant on-going revenue opportunities as the customer continues further development of its drug.
SQD.VN: 0.560 (-0.010)
SQI DIAGNOSTICS Receives FDA Clearance for its Ig_plex Celiac DGP Panel for Sale in the United States
PR Newswire - Thu Nov 13, 2:52PM CST
SQI Diagnostics Inc. (the "Company" or "SQI Diagnostics" (TSX-V: SQD) (OTCQX: SQIDF) today announced that it has received notice that the United States Food and Drug Administration (FDA) has cleared the Company to market its proprietary Celiac Panel in the United States (US).
SQD.VN: 0.560 (-0.010)
SQI Diagnostics to Present at the 15th Annual Immunogenicity for Biotherapeutics Conference
PR Newswire - Thu Nov 13, 2:13PM CST
SQI Diagnostics Inc. (TSX-V: SQD) (OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it will present at the Immunogenicity for Biotherapeutics Conference on Tuesday, October 21, 2014 in Boston, Massachusetts.
SQD.VN: 0.560 (-0.010)
IIROC Trade Resumption - SQI Diagnostics Inc.
Newsfile Corp - Mon Nov 10, 7:19AM CST
Trading resumes in:
IIROC Trade Halt - SQI Diagnostics Inc.
Newsfile Corp - Fri Nov 07, 2:23PM CST
The following issues have been halted by IIROC:
SQI Diagnostics Announces New Chairman of Board of Directors
PR Newswire - Mon Sep 29, 8:05AM CDT
SQI Diagnostics Inc. (TSX-V: SQD) (OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, is pleased to announce the appointment of Peter Winkley to Chairman of the Board of Directors of SQI, replacing Claude Ricks. Mr. Ricks will continue to serve as a Director on the Board and will continue to provide leadership to the Company.
SQD.VN: 0.560 (-0.010)
SQI Diagnostics Completes Tranche of Debenture Financing
CNW Group - Fri Jan 30, 2:01PM CST
SQI Diagnostics Inc. ("SQI" or the "Company"
(TSX-V: SQD; OTCQX: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it has closed the first tranche of its previously announced non-brokered private placement (the "Offering" of secured debentures for gross proceeds of $1.95 million. SQD.VN: 0.560 (-0.010)
SQI Diagnostics Announces Debt Financing of up to $4 Million
CNW Group - Wed Jan 21, 3:53PM CST
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES.
SQD.VN: 0.560 (-0.010)
SQI Diagnostics Reports Fourth Quarter and Fiscal 2014 Results
CNW Group - Wed Dec 17, 3:05PM CST
Solid Customer Growth Positions for Revenue Velocity in 2015
SQD.VN: 0.560 (-0.010)
SQI Diagnostics Wins Additional Business from UK-based Customer
PR Newswire - Mon Dec 15, 9:32AM CST
Technology Transfer Agreement Signals Revenue Growth Opportunities
SQD.VN: 0.560 (-0.010)
SQI Diagnostics to Announce Fourth Quarter and Fiscal 2014 Results
PR Newswire - Wed Dec 10, 4:00PM CST
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company"
(TSX-V: SQD; OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it plans to release its financial and operational results for the fourth quarter and fiscal year ended September 30, 2014, after market close on Wednesday, December 17, 2014. SQD.VN: 0.560 (-0.010)
S&P Capital IQ Initiates Coverage on SQI Diagnostics Inc. in S&P Capital IQ Factual Stock Reports
PR Newswire - Tue Dec 09, 5:10PM CST
S&P Capital IQ (MHFI) announced today that it has commenced Factual Stock Report coverage on SQI Diagnostics Inc.
MHFI: 102.19 (unch), SQD.VN: 0.560 (-0.010)
SQI DIAGNOSTICS Advances Commercial Opportunity with Leading Global Pharmaceutical Customer
PR Newswire - Mon Nov 24, 7:00AM CST
SQI Diagnostics Inc. ("SQI Diagnostics" or the "Company"
(TSX-V: SQD) (OTCQX: SQIDF) today announced that it has expanded its existing commercial relationship with one of the world's largest pharmaceutical companies. This final step in commercializing the Company's Ig_plex™ platform could lead to significant on-going revenue opportunities as the customer continues further development of its drug. SQD.VN: 0.560 (-0.010)
SQI DIAGNOSTICS Receives FDA Clearance for its Ig_plex Celiac DGP Panel for Sale in the United States
PR Newswire - Thu Nov 13, 2:52PM CST
SQI Diagnostics Inc. (the "Company" or "SQI Diagnostics"
(TSX-V: SQD) (OTCQX: SQIDF) today announced that it has received notice that the United States Food and Drug Administration (FDA) has cleared the Company to market its proprietary Celiac Panel in the United States (US). SQD.VN: 0.560 (-0.010)
SQI Diagnostics to Present at the 15th Annual Immunogenicity for Biotherapeutics Conference
PR Newswire - Thu Nov 13, 2:13PM CST
SQI Diagnostics Inc. (TSX-V: SQD) (OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it will present at the Immunogenicity for Biotherapeutics Conference on Tuesday, October 21, 2014 in Boston, Massachusetts.
SQD.VN: 0.560 (-0.010)
IIROC Trade Resumption - SQI Diagnostics Inc.
Newsfile Corp - Mon Nov 10, 7:19AM CST
Trading resumes in:
IIROC Trade Halt - SQI Diagnostics Inc.
Newsfile Corp - Fri Nov 07, 2:23PM CST
The following issues have been halted by IIROC:
SQI Diagnostics Announces New Chairman of Board of Directors
PR Newswire - Mon Sep 29, 8:05AM CDT
SQI Diagnostics Inc. (TSX-V: SQD) (OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, is pleased to announce the appointment of Peter Winkley to Chairman of the Board of Directors of SQI, replacing Claude Ricks. Mr. Ricks will continue to serve as a Director on the Board and will continue to provide leadership to the Company.
SQD.VN: 0.560 (-0.010)
(0)
(0)Scroll down for more posts ▼